Guardian Wealth Advisors (North Carolina)’s Boston Scientific BSX Stock Holding History

Guardian Wealth Advisors (North Carolina)’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,813	Closed	-$239K	–	399
2026 Q1	$239K	Buy	3,813 +118	+3%	+$9.44K	0.02%	317
2025 Q4	$352K	Sell	3,695 -25	-0.7%	-$2.45K	0.02%	272
2025 Q3	$363K	Buy	3,720 +155	+4%	+$16.1K	0.02%	260
2025 Q2	$383K	Buy	3,565 +1,036	+41%	+$105K	0.03%	229
2025 Q1	$255K	Sell	2,529 -69	-3%	-$6.95K	0.02%	273
2024 Q4	$232K	Buy	2,598 +205	+9%	+$18K	0.02%	292
2024 Q3	$201K	Buy	+2,393	New	+$189K	0.02%	269

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Guardian Wealth Advisors (North Carolina)'s BSX Position: Q2 2026 in Review

Guardian Wealth Advisors (North Carolina) sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 3,813 shares — an estimated $239K sold.

Guardian Wealth Advisors (North Carolina) first reported a position in BSX in Q3 2024 and held it in 7 quarters. The position peaked at $383K in Q2 2025. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Guardian Wealth Advisors (North Carolina) reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
Guardian Wealth Advisors (North Carolina) sold 3,813 Boston Scientific shares in Q2 2026, an estimated $239K.
Guardian Wealth Advisors (North Carolina) first reported a position in Boston Scientific in Q3 2024 and held it in 7 quarters.
Guardian Wealth Advisors (North Carolina)'s Boston Scientific position peaked at $383K in Q2 2025.
1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Guardian Wealth Advisors (North Carolina)'s 13F filing for Q2 2026, filed 14 Aug 2026.